Top upgrades and downgrades on 6/7

Analysts Notebook wrote a column · Jun 7, 2022 06:41

Upgrades

• $AmerisourceBergen (ABC.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $178 (from $167)

• $Arch Resources (ARCH.US)$ : Jefferies Upgrades to Buy From Hold - PT $225 (from $160)

• $BHP Group Ltd (BHP.US)$ : Jefferies Upgrades to Buy From Hold - PT $82 (from $72)

• $Peabody Energy (BTU.US)$ : Jefferies Upgrades to Buy From Hold - PT $36 (from $25)

• $Warrior Met Coal (HCC.US)$ : Jefferies Upgrades to Buy From Hold - PT $50 (from $36)

• $Liberty Global-A (LBTYA.US)$ : Berenberg Upgrades to Buy from Hold - PT $30

• $Lear (LEA.US)$ : Wells Fargo Upgrades to Overweight From Equal Weight - PT $180 (from $141)

• $McKesson (MCK.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $378 (from $343)

• $Ramaco Resources-A (METC.US)$ : Jefferies Upgrades to Buy From Hold - PT $25 (from $16)

• $Mirati Therapeutics (MRTX.US)$ : JMP Securities Upgrades to Market Outperform from Market Perform - PT $72

• $Plexus (PLXS.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $100

• $Rio Tinto (RIO.US)$ : Jefferies Upgrades to Buy From Hold - PT $93 (from $92)

• $Tyler Technologies (TYL.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $435 (from $425)

• $Vale SA (VALE.US)$ : Jefferies Upgrades to Buy From Hold - PT $24 (from $17)

• $Exxon Mobil (XOM.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $120 (from $88)

• $XP Inc (XP.US)$ : UBS Upgrades to Buy from Neutral - PT $31 (from $37)

Downgrades

• $Booz Allen Hamilton Holding Corp (BAH.US)$ : Barclays Downgrades to Equalweight from Overweight - PT $95

• $Devon Energy (DVN.US)$ : Evercore ISI Downgrades to In Line from Outperform - PT $80

• $Leidos (LDOS.US)$ : Barclays Downgrades to Equalweight from Overweight - PT $105

• $Occidental Petroleum (OXY.US)$ : Evercore ISI Downgrades to In Line from Outperform - PT $74

• $Praxis Precision Medicines (PRAX.US)$ : BofA Securities Downgrades to Neutral from Buy - PT $4 (from $26)

• $TherapeuticsMD (TXMD.US)$ : H.C. Wainwright Downgrades to Neutral from Buy

Initiated

• $Alnylam Pharmaceuticals (ALNY.US)$ : William Blair initiates at Outperform

• $Marqeta (MQ.US)$ : UBS initiates at Buy - PT $14

• $ProFrac Holding (PFHC.US)$ : JPMorgan initiates at Overweight - PT $25

• $RLI Corp (RLI.US)$ : Raymond James initiates at Market Perform

• $Transcode Therapeutics (RNAZ.US)$ : H.C. Wainwright initiates at Buy - PT $10

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

536K Views

Comment

Moomoo News Official Account

How do analysts evaluate the market?

19KFollowers

46Following

39KVisitors